HDAC Inhibitors Potentiate the Activity of the BCR/ABL...

Clinical Cancer Research 2011 / 05 Vol. 17; Iss. 10

HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo

Nguyen, T., Dai, Y., Attkisson, E., Kramer, L., Jordan, N., Nguyen, N., Kolluri, N., Muschen, M., Grant, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-11-0234
Date:
May, 2011
File:
PDF, 1.18 MB
english, 2011
Conversion to is in progress
Conversion to is failed